305 related articles for article (PubMed ID: 28544992)
1. Pharmacokinetics, pharmacodynamics, and tolerability of USL261, midazolam nasal spray: Randomized study in healthy geriatric and non-geriatric adults.
Berg AK; Myrvik MJ; Van Ess PJ
Epilepsy Behav; 2017 Jun; 71(Pt A):51-59. PubMed ID: 28544992
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics, pharmacodynamics, and safety of USL261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteers.
Bancke LL; Dworak HA; Rodvold KA; Halvorsen MB; Gidal BE
Epilepsia; 2015 Nov; 56(11):1723-31. PubMed ID: 26332539
[TBL] [Abstract][Full Text] [Related]
3. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers.
Knoester PD; Jonker DM; Van Der Hoeven RT; Vermeij TA; Edelbroek PM; Brekelmans GJ; de Haan GJ
Br J Clin Pharmacol; 2002 May; 53(5):501-7. PubMed ID: 11994056
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of a new highly concentrated intranasal midazolam formulation for conscious sedation.
Schrier L; Zuiker R; Merkus FW; Klaassen ES; Guan Z; Tuk B; van Gerven JM; van der Geest R; Groeneveld GJ
Br J Clin Pharmacol; 2017 Apr; 83(4):721-731. PubMed ID: 27780297
[TBL] [Abstract][Full Text] [Related]
6. Intranasal midazolam in piglets: pharmacodynamics (0.2 vs 0.4 mg/kg) and pharmacokinetics (0.4 mg/kg) with bioavailability determination.
Lacoste L; Bouquet S; Ingrand P; Caritez JC; Carretier M; Debaene B
Lab Anim; 2000 Jan; 34(1):29-35. PubMed ID: 10759364
[TBL] [Abstract][Full Text] [Related]
7. A pharmacokinetic and pharmacodynamic study, in healthy volunteers, of a rapidly absorbed intranasal midazolam formulation.
Wermeling DP; Record KA; Archer SM; Rudy AC
Epilepsy Res; 2009 Feb; 83(2-3):124-32. PubMed ID: 19046855
[TBL] [Abstract][Full Text] [Related]
8. Intranasal midazolam: a comparison of two delivery devices in human volunteers.
Dale O; Nilsen T; Loftsson T; Hjorth Tønnesen H; Klepstad P; Kaasa S; Holand T; Djupesland PG
J Pharm Pharmacol; 2006 Oct; 58(10):1311-8. PubMed ID: 17034653
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of midazolam following intravenous and intramuscular administration to sheep.
Simon BT; Scallan EM; O O; Ebner LS; Cerullo MN; Follette C; Cox SK; Doherty TJ; Lizarraga I
Am J Vet Res; 2017 May; 78(5):539-549. PubMed ID: 28441044
[TBL] [Abstract][Full Text] [Related]
10. Safety, Tolerability, and Pharmacokinetic Study of 101BHG-D01 Nasal Spray, a Novel Long-Acting and Selective Cholinergic M Receptor Antagonist, in Healthy Chinese Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation, First-In-Human Study.
Chu NN; Huang K; Que LL; Ding Y; Gu XH; Zhang L; Wang JK; Chen XP; Sun ZG; He Q
Eur J Drug Metab Pharmacokinet; 2022 Jul; 47(4):509-521. PubMed ID: 35429285
[TBL] [Abstract][Full Text] [Related]
11. Safety, Pharmacokinetics, and Pharmacodynamics of Midazolam Gel After Rectal Administration in Healthy Chinese Subjects.
Zhou S; Zhu J; Sun X; Xie L; Zhao Y; Ding S; Wang L; Chen J; Zhu B; Zheng A; Li Y; Zhou C; Shao F
Clin Drug Investig; 2023 Jun; 43(6):421-433. PubMed ID: 37270744
[TBL] [Abstract][Full Text] [Related]
12. Effect of saquinavir-ritonavir on cytochrome P450 3A4 activity in healthy volunteers using midazolam as a probe.
Schmitt C; Hofmann C; Riek M; Patel A; Zwanziger E
Pharmacotherapy; 2009 Oct; 29(10):1175-81. PubMed ID: 19792991
[TBL] [Abstract][Full Text] [Related]
13. The influence of parecoxib, a parenteral cyclooxygenase-2 specific inhibitor, on the pharmacokinetics and clinical effects of midazolam.
Ibrahim A; Karim A; Feldman J; Kharasch E
Anesth Analg; 2002 Sep; 95(3):667-73, table of contents. PubMed ID: 12198057
[TBL] [Abstract][Full Text] [Related]
14. Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses.
Moore KH; Hussey EK; Shaw S; Fuseau E; Duquesnoy C; Pakes GE
Cephalalgia; 1997 Jun; 17(4):541-50. PubMed ID: 9209776
[TBL] [Abstract][Full Text] [Related]
15. A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults.
Munjal S; Gautam A; Offman E; Brand-Schieber E; Allenby K; Fisher DM
Headache; 2016 Oct; 56(9):1455-1465. PubMed ID: 27613076
[TBL] [Abstract][Full Text] [Related]
16. A Two-way Randomized Cross-over Pharmacokinetic and Pharmacodynamic Study of an Innovative Oral Solution of Midazolam (ADV6209).
Guittet C; Manso M; Burton I; Granier LA; Marçon F
Pharm Res; 2017 Sep; 34(9):1840-1848. PubMed ID: 28577272
[TBL] [Abstract][Full Text] [Related]
17. Cinacalcet does not affect the activity of cytochrome P450 3A enzymes, a metabolic pathway for common immunosuppressive agents : a randomized, open-label, crossover, single-centre study in healthy volunteers.
Padhi D; Salfi M; Emery M
Drugs R D; 2008; 9(5):335-43. PubMed ID: 18721002
[TBL] [Abstract][Full Text] [Related]
18. Influence of the antibiotics erythromycin and azithromycin on the pharmacokinetics and pharmacodynamics of midazolam.
Zimmermann T; Yeates RA; Laufen H; Scharpf F; Leitold M; Wildfeuer A
Arzneimittelforschung; 1996 Feb; 46(2):213-7. PubMed ID: 8720318
[TBL] [Abstract][Full Text] [Related]
19. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM
Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and the pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extraction.
Platten HP; Schweizer E; Dilger K; Mikus G; Klotz U
Clin Pharmacol Ther; 1998 May; 63(5):552-60. PubMed ID: 9630828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
